Procter & Gamble Health Limited (NSE:PGHL)
India · Delayed Price · Currency is INR 5,263.50
+2.00 (0.04%)
Feb 4, 2026, 10:52 AM IST
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 87.36 billion as of February 3, 2026. Its market cap has decreased by -2.98% in one year.
Market Cap
87.36B
Enterprise Value
84.56B
Revenue
12.84B
Ranking
n/a
PE Ratio
28.48
Stock Price
5,263.50
Market Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 87.36B, an increase of 796.40%. That is a compound annual growth rate of 8.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 87.36B | -7.69% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 201.47B |
| Eris Lifesciences | 191.90B |
| Alembic Pharmaceuticals | 154.53B |
| NATCO Pharma | 146.48B |
| Cohance Lifesciences | 141.51B |
| Alivus Life Sciences | 112.27B |
| Strides Pharma Science | 79.50B |
| Akums Drugs and Pharmaceuticals | 68.15B |